/Cencora%20Inc_%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Headquartered in Conshohocken, Pennsylvania, Cencora, Inc. (COR) is a leading pharmaceutical services company dedicated to enhancing global healthcare. With a market cap of $47.7 billion, Cencora delivers innovative distribution and commercialization solutions, partnering with top pharmaceutical manufacturers, healthcare providers, and pharmacies to improve patient access to vital medications and therapies.
Cencora's shares have significantly underperformed the broader market over the past 52 weeks. COR has gained 5.9% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 20.5%. However, in 2025, the stock has returned 8.4% compared to SPX’s 2.9% gain on a YTD basis.